International Assets Investment Management’s VanEck Biotech ETF BBH Stock Holding History

International Assets Investment Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11	Closed	-$2.14K	–	2253
2025 Q4	$2.14K	Buy	+11	New	+$2.04K	﹤0.01%	1949
2024 Q4	–	Sell	-1,141,414	Closed	-$11.1K	–	916
2024 Q3	$11.1K	Buy	1,141,414 +1,141,403	+10,376,391%	+$203M	0.03%	405
2024 Q2	$1.88K	Buy	+11	New	+$1.8K	﹤0.01%	2015

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

International Assets Investment Management's BBH Position: Q1 2026 in Review

International Assets Investment Management sold out of VanEck Biotech ETF (BBH) in Q1 2026, closing a stake of 11 shares — an estimated $2.14K sold.

International Assets Investment Management first reported a position in BBH in Q2 2024 and held it in 3 quarters. The position peaked at $11.1K in Q3 2024. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

International Assets Investment Management reported no remaining VanEck Biotech ETF position as of Q1 2026 after selling out during the quarter.
International Assets Investment Management sold 11 VanEck Biotech ETF shares in Q1 2026, an estimated $2.14K.
International Assets Investment Management first reported a position in VanEck Biotech ETF in Q2 2024 and held it in 3 quarters.
International Assets Investment Management's VanEck Biotech ETF position peaked at $11.1K in Q3 2024.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on International Assets Investment Management's 13F filing for Q1 2026, filed 1 May 2026.